BusinessPhoto: BusinessLineConcord Biotech Drives Growth with Injectables and CDMO Ventures
Concord Biotech is maintaining its base growth while expanding its injectable products and CDMO (Contract Development and Manufacturing Organization) ventures. The company aims to recover profit margins and achieve steady growth supported by strong business fundamentals.
BusinessLine·




